We work with innovators of biotech, healthcare, science, sustainability, and advanced technology
rBIO biosimilar insulin advances to clinical trials — strategy by ZingPR
rBIO's biosimilar insulin story landed in Wired, MedCity News, and more. See the PR tactics that drove success and get tips for your biotech launch.
rBIO aims to reduce the cost of insulin by 30%
rBIO's platform for synthetic insulin achieves success as the team looks to production scale-up and a range of other prescription drugs to target.